News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
280,207 Results
Type
Article (14814)
Company Profile (299)
Press Release (265089)
Multimedia
Podcasts (73)
Webinars (11)
Section
Business (79786)
Career Advice (159)
Deals (13320)
Drug Delivery (38)
Drug Development (50670)
Employer Resources (31)
FDA (5824)
Job Trends (5163)
News (144994)
Policy (10067)
Tag
Academia (918)
Accelerated approval (18)
Adcomms (14)
Allergies (77)
Alliances (21761)
ALS (120)
Alzheimer's disease (1018)
Antibody-drug conjugate (ADC) (217)
Approvals (6004)
Artificial intelligence (237)
Autoimmune disease (97)
Automation (9)
Bankruptcy (105)
Best Places to Work (4560)
BIOSECURE Act (6)
Biosimilars (98)
Biotechnology (230)
Bladder cancer (95)
Brain cancer (43)
Breast cancer (324)
Cancer (2968)
Cardiovascular disease (227)
Career advice (145)
Career pathing (6)
CAR-T (210)
CDC (5)
Cell therapy (542)
Cervical cancer (14)
Clinical research (43434)
Collaboration (1040)
Company closure (2)
Compensation (552)
Complete response letters (36)
COVID-19 (1094)
CRISPR (81)
C-suite (491)
Cystic fibrosis (108)
Data (4116)
Denatured (13)
Depression (82)
Diabetes (245)
Diagnostics (1369)
Digital health (9)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (176)
Drug pricing (43)
Drug shortages (3)
Duchenne muscular dystrophy (202)
Earnings (31541)
Editorial (23)
Employer branding (4)
Employer resources (29)
Events (51427)
Executive appointments (608)
FDA (7442)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (20)
Funding (916)
Gene editing (169)
Generative AI (18)
Gene therapy (459)
GLP-1 (488)
Government (1140)
Grass and pollen (3)
Guidances (162)
Healthcare (6607)
HIV (15)
Huntington's disease (39)
IgA nephropathy (73)
Immunology and inflammation (178)
Immuno-oncology (27)
Indications (51)
Infectious disease (1193)
Inflammatory bowel disease (150)
Inflation Reduction Act (10)
Influenza (36)
Intellectual property (154)
Interviews (18)
IPO (7333)
IRA (12)
Job creations (867)
Job search strategy (129)
Kidney cancer (9)
Labor market (22)
Layoffs (241)
Leadership (9)
Legal (1400)
Liver cancer (40)
Longevity (9)
Lung cancer (407)
Lymphoma (241)
Machine learning (21)
Management (7)
Manufacturing (341)
MASH (128)
Medical device (2657)
Medtech (2664)
Mergers & acquisitions (6570)
Metabolic disorders (686)
Multiple sclerosis (94)
NASH (13)
Neurodegenerative disease (209)
Neuropsychiatric disorders (64)
Neuroscience (1872)
NextGen: Class of 2026 (2032)
Non-profit (864)
Now hiring (28)
Obesity (307)
Opinion (122)
Ovarian cancer (123)
Pain (91)
Pancreatic cancer (146)
Parkinson's disease (214)
Partnered (12)
Patents (281)
Patient recruitment (294)
Peanut (42)
People (26515)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase I (15381)
Phase II (20176)
Phase III (12762)
Pipeline (2689)
Policy (86)
Postmarket research (853)
Preclinical (6520)
Press Release (30)
Prostate cancer (138)
Psychedelics (48)
Radiopharmaceuticals (232)
Rare diseases (582)
Real estate (1446)
Recruiting (12)
Regulatory (9717)
Reports (19)
Research institute (968)
Resumes & cover letters (18)
Rett syndrome (21)
RNA editing (16)
RSV (16)
Schizophrenia (118)
Series A (169)
Series B (122)
Service/supplier (1)
Sickle cell disease (75)
Special edition (18)
Spinal muscular atrophy (118)
Sponsored (15)
Startups (2001)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (17)
The Weekly (59)
Vaccines (320)
Venture capital (59)
Weight loss (165)
Women's health (23)
Worklife (2)
Date
Today (89)
Last 7 days (295)
Last 30 days (1095)
Last 365 days (18149)
2026 (295)
2025 (18096)
2024 (20544)
2023 (22416)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (153)
Alabama (63)
Alaska (2)
Arizona (67)
Arkansas (5)
Asia (18161)
Australia (3084)
California (6744)
Canada (1777)
China (724)
Colorado (233)
Connecticut (239)
Delaware (224)
Europe (38949)
Florida (847)
Georgia (203)
Hawaii (2)
Idaho (17)
Illinois (373)
India (31)
Indiana (151)
Iowa (8)
Japan (205)
Kansas (79)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (714)
Massachusetts (5344)
Michigan (104)
Minnesota (239)
Mississippi (3)
Missouri (31)
Montana (15)
Nebraska (5)
Nevada (29)
New Hampshire (18)
New Jersey (1580)
New Mexico (12)
New York (1688)
North Carolina (794)
North Dakota (6)
Northern California (3278)
Ohio (173)
Oklahoma (11)
Oregon (23)
Pennsylvania (1220)
Puerto Rico (8)
Rhode Island (25)
South America (210)
South Carolina (9)
Southern California (2668)
Tennessee (38)
Texas (869)
United States (22311)
Utah (92)
Virginia (130)
Washington D.C. (36)
Washington State (562)
West Virginia (1)
Wisconsin (37)
280,207 Results for "spyre therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spyre Therapeutics Announces Grants of Inducement Awards - December 5, 2025
December 8, 2025
·
1 min read
Press Releases
Spyre Therapeutics Announces Grants of Inducement Awards - November 7, 2025
November 10, 2025
·
1 min read
Press Releases
Spyre Therapeutics to Participate in Upcoming November 2025 Investor Conferences
October 30, 2025
·
1 min read
Press Releases
Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025
October 27, 2025
·
5 min read
Press Releases
Spyre Therapeutics Announces Grants of Inducement Awards - October 3, 2025
October 5, 2025
·
1 min read
Press Releases
Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 4, 2025
·
17 min read
Press Releases
Spyre Therapeutics Announces Pricing of $275.0 Million Public Offering of Common Stock
October 14, 2025
·
6 min read
Press Releases
Spyre Therapeutics Announces Poster Presentations at United European Gastroenterology Week (UEGW) 2025
October 5, 2025
·
6 min read
Press Releases
Spyre Therapeutics Announces Positive Interim Phase 1 Results for SPY003, Its Novel, Half-Life Extended anti-IL-23 Antibody
November 4, 2025
·
9 min read
Press Releases
Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $316.2 Million
October 16, 2025
·
2 min read
1 of 28,021
Next
